Zynerba PharmaceuticalsZYNE
13F holders, Q1 2024 (March 31)1holders
$1.27avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Zynerba Pharmaceuticals Inc. (ZYNE) in their 13F filings. The largest holder was B. Riley Wealth Advisors, Inc. ($16K).
- Company
- Zynerba Pharmaceuticals Inc.
- CUSIP
- 98986X109
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $16K |
| Exits | 0 | $0 |
Ownership 1 holders
| B. Riley Wealth Advisors, Inc. | 0.00% | New | 12,732 | $16K |
"% of holder's portfolio" is ZYNE's weight in each manager's 13F, not the share of Zynerba Pharmaceuticals Inc. the manager owns.